Range
7.15 - 7.3
Vol / Avg.
572.1K/982.4K
Div / Yield
-
52 Wk
6.25 - 10.05
Mkt Cap
470.7M
Payout Ratio
-
Open
7.17
P/E
-
EPS
-0.26
Shares
65M
Outstanding
65M
Total Float
-
Benzinga - Jun 1, 2021, 5:21AM
Benzinga - Mar 23, 2021, 7:30AM
load more
Sector: Health Care.Industry: Biotechnology
CytomX Therapeutics Inc is an oncology-focused biopharmaceutical company which is operating in the United States. It is engaged in developing antibody therapeutics based on probody technology platform. The company probody technology platform to create proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of unique conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues. The company focuses on developing Probody therapeutics which addresses clinically-validated cancer targets in immuno-oncology that are difficult to drug and lead to concerns about damage to healthy tissues or toxicities.

Earnings

see more
Q2 2021Est.ActualSurprise
EPS
(EXPECTED)2021-08-05
REV
Q1 2021Est.ActualSurprise
EPS-0.350-0.260 0.0900
REV15.430M15.971M541.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
CTMXCytomX Therapeutics0%470.7M

CytomX Therapeutics Frequently Asked Questions

Q

How do I buy CytomX Therapeutics (CTMX) stock?

A

You can purchase shares of CytomX Therapeutics (NASDAQ: CTMX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are CytomX Therapeutics's (CTMX) competitors?

Q

What is the target price for CytomX Therapeutics (CTMX) stock?

A

The latest price target for CytomX Therapeutics (NASDAQ: CTMX) was reported by Barclays on May 28, 2021. The analyst firm set a price target for 7.00 expecting CTMX to fall to within 12 months (a possible -3.31% downside). 4 analyst firms have reported ratings in the last year.

Q

Current Stock Price for CytomX Therapeutics (CTMX)?

A

The stock price for CytomX Therapeutics (NASDAQ: CTMX) is $7.24 last updated Today at 8:00:03 PM.

Q

Does CytomX Therapeutics (CTMX) pay a dividend?

A

There are no upcoming dividends for CytomX Therapeutics.

Q

When is CytomX Therapeutics (NASDAQ:CTMX) reporting earnings?

A
CytomX Therapeutics’s Q2 earnings are confirmed for after-market on August 5, 2021.
Q

Is CytomX Therapeutics (CTMX) going to split?

A

There is no upcoming split for CytomX Therapeutics.

Q

What sector and industry does CytomX Therapeutics (CTMX) operate in?

A

CytomX Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.